Mark Euwe
About Mark Euwe
Posts by Mark Euwe:
Gilbert achieves ISO-13485 Certification
Gilbert would like to acknowledge the monumental achievement of the entire team in attaining the ISO 13485:2016 certification by TÜV SÜD, demonstrating the company’s commitment to compliance with the highest level of internationally recognized quality standards.
“We are proud of the robust quality management system our team has built, ensuring stringent control over design and development processes,” said Maurits Huigen, Chief Executive Officer of Gilbert. “This certification demonstrates our ability to meet exacting regulatory requirements as we continue to achieve the developmental milestones for our Smart Precision Inhaler platform.”
Gilbert successfully completed audits by TÜV SÜD to verify that it has established and is maintaining a quality management system that meets all requirements of the ISO 13485:2016 standard for design and development of Gilbert’s products.
ISO 13485 is an internationally recognized quality standard for quality management systems, created by the International Organization for Standardization to ensure the safety and effectiveness of medical devices. It builds on the ISO 9001 standard with additional regulatory requirements specific to medical devices. In 2025, the U.S. Food and Drug Administration issued the Quality Management System Regulation (QMSR) Final Rule, which harmonizes U.S. requirements with global standards through the adoption of ISO 13485 standards for medical devices.
Gilbert featured in extensive Brainport article
Gilbert is proud to be featured in a publication of Brainport Eindhoven, titled ‘Innovation and Impact in Inhalation Therapy from the Heart of the Brainport Region’, being one of the MedTech Pioneers in the Brainport region. CEO Maurits Huigen and CCO Scott Fleming share their vision on the company and its Smart Precision Inhaler.
The article describes the university roots of the company and explains the potential of our disruptive, proprietary electrospray technology based, inhaler device and wide set of applications. Gilbert is proud and grateful to be part of the Brainport ecosystem, which has been instrumental to the success of the company so far.
The full article can be found here.
Gilbert selected as Deep Tech Pioneer by Hello Tomorrow
We’re privileged to announce that we’ve been selected as one of the esteemed Hello Tomorrow Deep Tech Pioneers. Out of thousands of applications, our Smart Precision Inhaler solution stood out to their experts, and we couldn’t be more excited!
Dutch deep-tech investor DeepTechXL is truly excited that Gilbert, one of DeepTechXL’s disruptive technology portfolio companies, has been selected out of thousands of applicants by Hello Tomorrow. This reward underpins the novelty of Gilbert’s proprietary smart precision inhaler and emphasizes its potential to have a positive societal impact with improved drug delivery and therapy adherence for millions of patients.
Join us at the 10th Hello Tomorrow Global Summit in Paris on March 13-14, 2025, and connect with the world’s top innovators, industry leaders, investors, and deep tech visionaries.
Let’s shape the future of deep tech together to redefine treatment for lung patients!
Don’t miss out! 👉Global Summit – Hello Tomorrow
Gilbert joins DDL 2024 in Edinburgh
Gilbert looks forward to attending the annual DDL (Drug Delivery to the Lungs) conference in Edinburgh from Dec 11th-13th.
This year DDL is celebrating its 35th anniversary and this promises to be a landmark event attracting over 1000 scientists, academics, clinicians, regulators and industry experts worldwide, all with a focus on improving pulmonary drug delivery for serious lung diseases.
As we are working hard on the development of our Smart Precision Inhaler, we are especially looking forward to the session on Gene Therapy & Biologics for the Lungs and to explore how we can enable and improve the delivery of these important advances in treatment.
With mono-dispersed and customizable aerosol generation, we believe that Gilbert’s electrospray soft mist inhaler may hold significant promise for improved targeting and delivery of these innovative medicines.
Let’s redefine treatment for lung patients together!
So if you are also joining, let’s meet up in Edinburgh!
To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Scott Fleming, Mehmet Uzumcu or Maurits Huigen who will all be there.
Exploring the Future of Inhalation Drug Delivery
The Gilbert team looks forward to attending the International Conference on “Exploring the Future of Inhalation Drug Delivery“, organized by the University of Parma and supported by the Galenus Foundation, in Parma, Italy from Sept 11th-13th.
As we are working hard on the development of our Smart Precision Inhaler, we look forward to connecting with professionals working on improvements in formulation and development of inhaled medicine.
With customizable aerosol generation, we believe that Gilbert’s electrospray soft mist inhaler may hold significant promise for the delivery of the innovative medicines under research today.
Let’s redefine treatment for lung patients together!
So if you are also visiting, let’s meet up in Parma!
To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Mehmet Uzumcu, Scott Fleming or Fatemeh Jahanmard who will be visiting the conference.
Gilbert joins ERS Congress in Vienna
The Gilbert team looks forward to attending the European Respiratory Society (ERS) in Vienna from Sept 7th-11th.
Our special interest is to catch up on the latest research in inhaled drug delivery therapies.
We look forward to connect with pharma and biotech decision makers to redefine treatment for lung patients together.
So if you are also visiting, let’s meet up in Vienna!
To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Maurits Huigen or Scott Fleming.
